(HealthDay)—Retacrit (epoetin alfa-epbx) has been approved by the U.S. Food and Drug Administration as the first "biosimilar" to the anemia drugs Epogen and Procrit.
May 15, 2018
0
2
(HealthDay)—The U.S. Food and Drug Administration has expanded its approval of the multiple sclerosis drug Gilenya (fingolimod) to include children aged 10 and older.
May 14, 2018
0
1
(HealthDay)—Production issues have made EpiPens hard to find in some areas of the United States, the U.S. Food and Drug Administration announced Wednesday.
May 9, 2018
0
26
Several herbal remedies have been studied as a treatment for anxiety, but more research is needed to understand the risks and benefits. Here's what we know—and don't know:
Apr 26, 2018
0
13
New evidence from a Cochrane review published today, led by a University of Birmingham scientist, suggests that alternative drugs may be more effective than the standard drug currently used to stop women bleeding after childbirth.
Apr 26, 2018
0
28
A molecule has been identified that appears to play an important role in the development of Parkinson's disease, a debilitating disease that affects millions of people around the world.
Apr 20, 2018
1
1536
A new report in JAMA Internal Medicine by University of Sydney and Bond University scholars weighs the risks and benefits of a recent change to blood pressure guidelines in the US.
Apr 16, 2018
0
1143
Commonly used medications for high blood pressure and high blood lipids have substantial effects on protein biomarkers for cardiovascular disease, cancer and various inflammatory markers. This effect is evident also after ...
Apr 5, 2018
0
2
How often to you read headlines proclaiming the arrival of a new, ground-breaking treatment for Alzheimer's?
Mar 19, 2018
0
10
A drug commonly used to control high blood pressure may also help prevent the onset of type 1 diabetes in up to 60 percent of those at risk for the disease, according to researchers at the University of Colorado Anschutz ...
Feb 15, 2018
0
507
